1 / 8

AI in Precision Medicine Market: Paving the Way for Targeted Therapies

AI in Precision Medicine Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision), Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Others), and Region (North America, Europe, Asia Pacific, RoW) u2013 Global Forecast to 2027

avinashgogawale14
Download Presentation

AI in Precision Medicine Market: Paving the Way for Targeted Therapies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Artificial Intelligence (AI) in precision medicine involves the use of genomic data of an individual to develop personalized medicine. Genomic data is being accumulated in significant quantities, providing scientists the ability to study how genetic factors, such as mutations lead to diseases. AI, especially deep learning, can capture patient data from electronic health records, prescriptions, genomic profiles, insurance records, and wearable devices. With this data, it is possible to create treatment plans for patients. diagnostic imaging systems,

  2. MarketsandMarkets Presents Drivers: Technological advancements in cancer biology will drive the AI in precision medicine market growth The technological developments across cancer biologics is expected to drive the growth of AI in precision medicine market over the forecast period. The presence of AI based computational tools along with availability of large sets of human genome databases have resulted into strong enhancements in the precision medicines. Industry participants are emphasizing on strategic partnership and collaboration activities to accelerate developments across cancer biology and develop precision medicines in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1537 86351

  3. MarketsandMarkets Presents Drivers: Technological advancements in cancer biology will drive the AI in precision medicine market growth For instance, in June 2022, GE Healthcare (US) announced strategic collaboration with Minerva Imaging (Denmark) for the advancements in the precision medicine for oncology treatments. The partnership emphasizes on leveraging the Radionuclide therapy, which is a type of precision medicine in which a radioactive substance is supervised across bloodstream in order to target the cancer cells and irradiate them without potential side effects compared to traditional cancer therapies. Such developments and partnership activities will fuel the AI in precision medicine market growth over the forecast timeframe.

  4. MarketsandMarkets Presents Growth of the geriatric population across the globe There has been a significant growth observed in the geriatric population and it is expected to continue in coming years. For instance, according to the October 2022 statistics by World Health Organization (WHO), one out of every 6 people in the world will be aged over 60 years or over by 2030. Also, by 2050, the population of people aged 60 years and older will be doubled, which is around 2.1 billion. The risks of infections across geriatric population is more compared to the younger people or population. This will increase the adoption of AI-based precision medicines over the forecast timeline. Speak to https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=15 3786351 Analyst @

  5. MarketsandMarkets Presents Challenges: High cost associated with the precision medicines pose a major challenge The research & development costs incurred for the AI-based precision medicine is on the higher side in comparison to the traditional medicines. These medicines are expensive to produce as they are specifically designed for an individual patient and not for the mass market. Adding to this, significant threat to personal health data also pose a challenge to the growth of AI in precision medicine market.

  6. MarketsandMarkets Presents Key Players in the market BioXcel Therapeutics Inc. (US), GE Healthcare (US), Insilico Medicine (US), Intel Corporation (US), Microsoft (US), Tempus (US), NVIDIA Corporation (US), Sanofi (France), Sensely, Inc. (US), Zephyr AI (US) are few key players in the AI in Precision Medicine Market globally. Browse https://www.marketsandmarkets.com/Market-Reports/ai-in- precision-medicine-market-153786351.html For More Details -

  7. MarketsandMarkets Presents About MarketsandMarkets™ MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

  8. MarketsandMarkets Presents Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: https://www.marketsandmarkets.com

More Related